Tesamorelin is a synthetic growth hormone–releasing hormone (GHRH) analog commonly studied for its effects on growth hormone signaling, insulin-like growth factor 1 (IGF-1) activity, and metabolic regulation. In research settings, tesamorelin has been investigated for its potential influence on body composition, lipid metabolism, and visceral adipose tissue dynamics.
This peptide consists of a modified 44–amino acid sequence designed to enhance stability and extend biological activity compared to endogenous GHRH. Researchers frequently examine tesamorelin in studies related to endocrine function, metabolism, aging, and hormone-response pathways. Tesamorelin is provided strictly for research use only and is not intended for human consumption.